Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EBT: 2010-2018

Historic EBT for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Jun 2018 value amounting to -$53.2 million.

  • EyePoint Pharmaceuticals' EBT fell 139.24% to -$14.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$34.6 million, marking a year-over-year decrease of 99.88%. This contributed to the annual value of -$53.2 million for FY2018, which is 187.64% down from last year.
  • As of FY2018, EyePoint Pharmaceuticals' EBT stood at -$53.2 million, which was down 187.64% from -$18.5 million recorded in FY2017.
  • EyePoint Pharmaceuticals' EBT's 5-year high stood at $8.1 million during FY2015, with a 5-year trough of -$53.2 million in FY2018.
  • Its 3-year average for EBT is -$31.1 million, with a median of -$21.7 million in 2016.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' EBT spiked by 160.22% in 2015, and later plummeted by 367.27% in 2016.
  • Over the past 5 years, EyePoint Pharmaceuticals' EBT (Yearly) stood at -$13.5 million in 2014, then spiked by 160.22% to $8.1 million in 2015, then tumbled by 367.27% to -$21.7 million in 2016, then rose by 14.82% to -$18.5 million in 2017, then slumped by 187.64% to -$53.2 million in 2018.